Awarded Contract
  • Compounded Pharmaceuticals

  • Standing Offer
  • Awarded
  • DOH-6031
  • 26/11/2025
  • From 01/12/2025 to 30/11/2028
  • This contract has an option to extend beyond this period.
  • This is a recurrent contract.

  • From 01/12/2028 to 30/11/2031
Business Is this a Tasmanian Business ? ** Business Address
Slade Health Pty Ltd No
11-13 Palmer Court
Mt Waverly
Victoria
Australia 3149
Fresenius Kabi Australia Pty Ltd No
Level 2, 2 Woodland Way
Mount Kuring-gai
Victoria
Australia 2080
*Additional supplier information may be added to this notice as contracts are finalised.
**A Tasmanian business is a business operating in Tasmania that has a permanent office or presence in Tasmania and which employs Tasmanian workers.

  • $161,151,330
3
  • $161,151,330
  • $16,115,133
  • $177,266,463 (This does not include the value of the option to extend.)
  • $161,151,330

  • 0
  • 3
  • Department of Health
  • GPO Box 125
  • Hobart TAS 7000
  • Pharmaceutical Products incl. Contraceptives and Vaccines

The production and delivery of compounded pharmaceutical products in patient specific forms.

Category 1 - Oncology and Immunotherapies - including Oncology Monoclonal Antibodies

Category 2 - Non-oncology Monoclonal Antibodies

Category 3 - Antibiotics

Category 4 - Total Parenteral Nutrition, and

Category 5 - General Compounding.

  • State-wide
Peta Jackson
cqra.mga@health.tas.gov.au

Please wait....

Dont hit the back button or any other buttons, a response receipt will come back shortly!

Your session has timed out. To continue on this page, please refresh by pressing F5.